The Global and Professional Direct Contracting model is going to be replaced with a new accountable care organization (ACO) model, which addresses some of the pushback there had been on the direct contracting model, said Michael Chernew, PhD.
The Global and Professional Direct Contracting model is going to be replaced with a new accountable care organization (ACO) model, which addresses some of the pushback there had been on the direct contracting model, said Michael Chernew, PhD, Leonard D. Schaeffer Professor of Health Care Policy and director of the Healthcare Markets and Regulation Lab at Harvard Medical School; chair of the Medicare Payment Advisory Commission; and co-editor-in-chief of The American Journal of Managed Care®.
Transcript:
What are the benefits of a direct contracting model? How is it supposed to address and improve outcomes?
A direct contracting model, in my view, is really just a version of the accountable care model. And in fact, you can see when they move from direct contracting over to ACO REACH, they've renamed it an ACO model, which I think in a number of ways, is more appropriate. And the advantage of this particular model, of course, is in many ways, it's a high-powered model. There's significant symmetric risk. You could have done that in any other ACO model. You could have done it, for example, in versions of MSSP [Medicare Shared Savings Program], if you made some of these changes.
So, the direct contracting piece of it, I think, is relatively minor. There are people that believe the nature of the change in the cash flow and the opening it up to some organizations will enable entities to enter that may be able to perform better than some of the traditional ACOs, and they will like some of the cash flow rules associated with that. That may end up proving to be true, I'm not sure that it will. And of course, that same expansion of the people participating, in many ways, is what has caused some of the pushback from some quarters.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More